|
CN101636179B
(zh)
|
2006-11-07 |
2012-10-10 |
默沙东公司 |
Pcsk9拮抗剂
|
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
|
US10611835B2
(en)
*
|
2008-07-10 |
2020-04-07 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and prevention of cancer
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
US20130064834A1
(en)
|
2008-12-15 |
2013-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to pcsk9
|
|
US8357371B2
(en)
|
2008-12-15 |
2013-01-22 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to PCSK9
|
|
MX2012002639A
(es)
|
2009-09-03 |
2012-03-14 |
Pfizer Vaccines Llc |
Vacuna de pcsk9.
|
|
WO2011053783A2
(en)
*
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Ax213 and ax132 pcsk9 antagonists and variants
|
|
AR079336A1
(es)
*
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
|
US8420098B2
(en)
*
|
2010-04-13 |
2013-04-16 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind to PCSK9
|
|
BR112012028764A2
(pt)
|
2010-05-11 |
2017-03-14 |
Aveo Pharmaceuticals Inc |
anticor-pos antifgfr2
|
|
GB2481373A
(en)
*
|
2010-06-21 |
2011-12-28 |
Weiming Xu |
Treatment of hypercholesterolaemia by ubiquitination of PCSK9
|
|
JO3756B1
(ar)
|
2010-11-23 |
2021-01-31 |
Regeneron Pharma |
اجسام مضادة بشرية لمستقبلات الجلوكاجون
|
|
MX2013007168A
(es)
*
|
2010-12-22 |
2013-11-04 |
Genentech Inc |
Anticuerpo anti-pcsk9 y metodos de uso.
|
|
WO2012101253A1
(en)
*
|
2011-01-28 |
2012-08-02 |
Sanofi |
Pharmaceutical compositions comprising human antibodies to pcsk9
|
|
EP2731623A1
(en)
|
2011-07-14 |
2014-05-21 |
Pfizer Inc |
Treatment with anti-pcsk9 antibodies
|
|
AR087305A1
(es)
|
2011-07-28 |
2014-03-12 |
Regeneron Pharma |
Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit
|
|
HRP20241450T1
(hr)
*
|
2011-09-16 |
2025-01-03 |
Regeneron Pharmaceuticals, Inc. |
Postupci za smanjivanje razina lipoproteina(a) putem primjene inhibitora proproteinske konvertaze suptilizin keksin 9 (pcsk9)
|
|
AR087715A1
(es)
|
2011-09-16 |
2014-04-09 |
Lilly Co Eli |
Anticuerpos anti pcsk9 y usos de los mismos
|
|
JP6635655B2
(ja)
|
2011-12-08 |
2020-01-29 |
アムジエン・インコーポレーテツド |
ヒトｌｃａｔ抗原結合タンパク質および治療法におけるそれらの使用
|
|
CA2859226C
(en)
*
|
2011-12-20 |
2020-07-21 |
Adaerata, Limited Partnership |
Single domain antibodies as inhibitors of pcsk9
|
|
AU2013204581B2
(en)
|
2012-03-16 |
2015-06-25 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals expressing pH-sensitive immunoglobulin sequences
|
|
NZ712508A
(en)
|
2012-03-16 |
2018-06-29 |
Regeneron Pharma |
Non-human animals expressing ph-sensitive immunoglobulin sequences
|
|
US20140013456A1
(en)
|
2012-03-16 |
2014-01-09 |
Regeneron Pharmaceuticals, Inc. |
Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
|
|
RS57414B1
(sr)
|
2012-03-16 |
2018-09-28 |
Regeneron Pharma |
Antitela sa lakim lancem konstruisanim sa histidinom i genetički modifikovani glodari za generisanje istih
|
|
US9255154B2
(en)
*
|
2012-05-08 |
2016-02-09 |
Alderbio Holdings, Llc |
Anti-PCSK9 antibodies and use thereof
|
|
WO2013188855A1
(en)
*
|
2012-06-15 |
2013-12-19 |
Genentech, Inc. |
Anti-pcsk9 antibodies, formulations, dosing, and methods of use
|
|
TWI596115B
(zh)
|
2012-08-13 |
2017-08-21 |
再生元醫藥公司 |
具有ｐＨ－依賴性結合特性之抗－ＰＣＳＫ９抗體
|
|
AU2013348071B2
(en)
|
2012-11-21 |
2018-05-24 |
Amgen Inc. |
Drug delivery device
|
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
|
CA2906508A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Amgen, Inc. |
Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
|
|
JP6768501B2
(ja)
|
2013-03-15 |
2020-10-14 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入機、および自動注入機システム
|
|
WO2014149699A1
(en)
|
2013-03-15 |
2014-09-25 |
Eli Lilly And Company |
Bifunctional protein
|
|
BR112015022042B1
(pt)
|
2013-03-15 |
2023-01-10 |
Amgen Inc |
Injetor para injetar um produto terapêutico
|
|
AU2014238267B2
(en)
|
2013-03-22 |
2019-08-15 |
Amgen Inc. |
Injector and method of assembly
|
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
|
EP2810955A1
(en)
|
2013-06-07 |
2014-12-10 |
Sanofi |
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
|
|
WO2014197752A1
(en)
|
2013-06-07 |
2014-12-11 |
Regeneron Pharmaceuticals, Inc. |
Methods fo inhibting atherosclerosis by administering an inhibitor of pcsk9
|
|
EP2862877A1
(en)
|
2013-10-18 |
2015-04-22 |
Sanofi |
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
|
|
CA2916259C
(en)
|
2013-06-28 |
2024-02-20 |
Amgen Inc. |
Methods for treating homozygous familial hypercholesterolemia
|
|
US10035847B2
(en)
|
2013-10-02 |
2018-07-31 |
The Rockefeller University |
Amyloid protofibril antibodies and methods of use thereof
|
|
EP3421066B1
(en)
|
2013-10-24 |
2021-03-03 |
Amgen Inc. |
Injector and method of assembly
|
|
US10758683B2
(en)
|
2013-10-24 |
2020-09-01 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
US10428157B2
(en)
|
2013-11-12 |
2019-10-01 |
Sanofi Biotechnology |
Dosing regimens for use with PCSK9 inhibitors
|
|
EP3076994A4
(en)
*
|
2013-12-06 |
2017-06-07 |
Modernatx, Inc. |
Targeted adaptive vaccines
|
|
US8945560B1
(en)
|
2014-07-15 |
2015-02-03 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
US9023359B1
(en)
|
2014-07-15 |
2015-05-05 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
US8986691B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
|
US8883157B1
(en)
|
2013-12-17 |
2014-11-11 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
US9045548B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
|
DE202014010499U1
(de)
|
2013-12-17 |
2015-10-20 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
US9034332B1
(en)
|
2014-07-15 |
2015-05-19 |
Kymab Limited |
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
|
US9051378B1
(en)
|
2014-07-15 |
2015-06-09 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
CN106413779B
(zh)
|
2014-05-07 |
2020-06-05 |
安姆根有限公司 |
具有减震元件的自助注射器
|
|
SG11201609970VA
(en)
|
2014-06-03 |
2016-12-29 |
Amgen Inc |
Systems and methods for remotely processing data collected by a drug delivery device
|
|
EP4328245A3
(en)
|
2014-07-15 |
2024-06-05 |
Kymab Ltd. |
Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
|
|
US9150660B1
(en)
|
2014-07-15 |
2015-10-06 |
Kymab Limited |
Precision Medicine by targeting human NAV1.8 variants for treatment of pain
|
|
DE202015009002U1
(de)
|
2014-07-15 |
2016-08-18 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
|
EP3332790A1
(en)
|
2014-07-15 |
2018-06-13 |
Kymab Limited |
Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
|
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
|
EP3169353B1
(en)
|
2014-07-16 |
2019-12-18 |
Sanofi Biotechnology |
Methods for treating patients with heterozygous familial hypercholesterolemia (hefh)
|
|
WO2016020799A1
(en)
|
2014-08-06 |
2016-02-11 |
Rinat Neuroscience Corp. |
Methods for reducing ldl-cholesterol
|
|
JP2017523980A
(ja)
|
2014-08-06 |
2017-08-24 |
ライナット ニューロサイエンス コーポレイション |
Ｌｄｌ−コレステロールを低下させるための方法
|
|
WO2016023916A1
(en)
|
2014-08-12 |
2016-02-18 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
|
US9657099B2
(en)
|
2014-09-16 |
2017-05-23 |
Regeneron Pharmaceuticals, Inc. |
Anti-glucagon antibodies
|
|
US10472424B2
(en)
|
2014-09-23 |
2019-11-12 |
Pfizer Inc. |
Treatment with anti-PCSK9 antibodies
|
|
CA2957960C
(en)
|
2014-10-14 |
2023-08-22 |
Amgen, Inc. |
Drug injection device with visual and audible indicators
|
|
BR112017008125B1
(pt)
|
2014-10-23 |
2023-11-21 |
Amgen Inc. |
Método para a redução da viscosidade de formulações farmacêuticas, formulações farmacêuticas, método de preparação de um pó liofilizado, pó liofilizado e método para reconstituição de um pó liofilizado
|
|
WO2016071701A1
(en)
|
2014-11-07 |
2016-05-12 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
|
MA41022A
(fr)
*
|
2014-11-24 |
2017-10-03 |
Shire Human Genetic Therapies |
Ciblage lysosomial et utilisations correspondantes
|
|
WO2016100781A1
(en)
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
EP3233159B1
(en)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
CN105461809B
(zh)
|
2015-02-11 |
2018-10-12 |
康融东方（广东）医药有限公司 |
Pcsk9抗体、其药物组合物及其用途
|
|
AU2016220141B2
(en)
|
2015-02-17 |
2018-07-12 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3981450A1
(en)
|
2015-02-27 |
2022-04-13 |
Amgen, Inc |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
JP6869894B2
(ja)
|
2015-03-20 |
2021-05-12 |
オーフス ウニベルシテット |
リポタンパク質代謝障害の治療のためのｐｃｓｋ９阻害剤
|
|
CN105037554B
(zh)
*
|
2015-06-12 |
2019-04-12 |
成都贝爱特生物科技有限公司 |
抗人pcsk9抗体的制备及其用途
|
|
CN107922507B
(zh)
|
2015-08-18 |
2022-04-05 |
瑞泽恩制药公司 |
抗pcsk9抑制性抗体用来治疗接受脂蛋白单采的高脂血症患者
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
WO2017055966A1
(en)
|
2015-10-01 |
2017-04-06 |
Pfizer Inc. |
Low viscosity antibody compositions
|
|
CN106810609A
(zh)
*
|
2015-11-27 |
2017-06-09 |
苏州君盟生物医药科技有限公司 |
抗pcsk9抗体及其应用
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
RU2739208C2
(ru)
*
|
2015-12-31 |
2020-12-21 |
Цзянсу Хэнжуй Медицин Ко., Лтд. |
Анти-pcsk9 антитело, его антигенсвязывающий фрагмент и их медицинское применение
|
|
JP2019509714A
(ja)
*
|
2016-01-05 |
2019-04-11 |
ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． |
Ｐｃｓｋ９抗体、その抗原結合フラグメント及び医薬用途
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
CA3010756A1
(en)
*
|
2016-01-13 |
2017-07-20 |
Novo Nordisk A/S |
Egf(a) analogues with fatty acid substituents
|
|
EP4035711B1
(en)
|
2016-03-15 |
2025-06-04 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
CN107266575B
(zh)
*
|
2016-04-07 |
2021-12-24 |
天士力生物医药股份有限公司 |
前蛋白转化酶枯草溶菌素kexin 9型的结合蛋白及其应用
|
|
US11016085B2
(en)
|
2016-04-25 |
2021-05-25 |
The Johns Hopkins University |
ZNT8 assays for drug development and pharmaceutical compositions
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
MX2018013616A
(es)
|
2016-05-13 |
2019-02-21 |
Amgen Inc |
Montaje de cubierta protectora de vial.
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
US11104724B2
(en)
|
2016-05-23 |
2021-08-31 |
New York University |
Compositions and methods for antibodies targeting staphylococcal leukotoxins
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
CN107474140B
(zh)
*
|
2016-06-08 |
2022-06-03 |
常州博嘉生物医药科技有限公司 |
Pcsk9特异性的结合蛋白mv072及其应用
|
|
JP7461741B2
(ja)
|
2016-06-20 |
2024-04-04 |
カイマブ・リミテッド |
抗ｐｄ－ｌ１およびｉｌ－２サイトカイン
|
|
CN109475593A
(zh)
*
|
2016-06-24 |
2019-03-15 |
豪夫迈·罗氏有限公司 |
用于治疗心血管疾病的组合物和方法
|
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018054241A1
(en)
*
|
2016-09-20 |
2018-03-29 |
Wuxi Biologics (Shanghai) Co., Ltd. |
Novel anti-pcsk9 antibodies
|
|
WO2018054240A1
(en)
*
|
2016-09-20 |
2018-03-29 |
Wuxi Biologics (Shanghai) Co. Ltd. |
Novel anti-pcsk9 antibodies
|
|
JP7046381B2
(ja)
|
2016-09-20 |
2022-04-04 |
オーフス ウニベルシテット |
リポタンパク質代謝障害の治療のための化合物
|
|
WO2018067987A1
(en)
|
2016-10-06 |
2018-04-12 |
Amgen Inc. |
Reduced viscosity protein pharmaceutical formulations
|
|
EP3529278A1
(en)
|
2016-10-20 |
2019-08-28 |
Regeneron Pharmaceuticals, Inc. |
Methods of lowering blood glucose levels
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
|
JOP20190112A1
(ar)
|
2016-11-14 |
2019-05-14 |
Amgen Inc |
علاجات مدمجة لتصلب الشرايين، شاملة مرض قلبي وعائي تصلبي
|
|
CN108239150A
(zh)
*
|
2016-12-24 |
2018-07-03 |
信达生物制药(苏州)有限公司 |
抗pcsk9抗体及其用途
|
|
JP2020503976A
(ja)
|
2017-01-17 |
2020-02-06 |
アムジエン・インコーポレーテツド |
注入デバイスならびに関連する使用および組立方法
|
|
EP3582825A1
(en)
|
2017-02-17 |
2019-12-25 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
WO2018152073A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
JP7377596B2
(ja)
*
|
2017-02-22 |
2023-11-10 |
アムジエン・インコーポレーテツド |
低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
|
|
MX2019010544A
(es)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
|
|
IL268478B2
(en)
|
2017-03-07 |
2023-10-01 |
Amgen Inc |
Inserting a needle using super pressure
|
|
EP3592404A1
(en)
|
2017-03-09 |
2020-01-15 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
KR102517342B1
(ko)
|
2017-03-28 |
2023-03-31 |
암겐 인코포레이티드 |
플런저 로드 및 주사기 조립 시스템 및 방법
|
|
ES3036143T3
(en)
|
2017-04-28 |
2025-09-15 |
Amgen Inc |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
|
WO2018226515A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
WO2018226565A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
US11541183B2
(en)
|
2017-06-22 |
2023-01-03 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
MA49461A
(fr)
|
2017-06-23 |
2020-04-29 |
Amgen Inc |
Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur
|
|
CN111316099A
(zh)
|
2017-07-12 |
2020-06-19 |
约翰霍普金斯大学 |
用于1型糖尿病诊断的基于脂蛋白体的znt8自身抗原
|
|
IL270784B2
(en)
|
2017-07-14 |
2023-11-01 |
Amgen Inc |
Needle insertion-extraction system with a double torsion spring system
|
|
TW201918494A
(zh)
|
2017-07-19 |
2019-05-16 |
丹麥商諾佛 儂迪克股份有限公司 |
雙功能性化合物
|
|
WO2019018538A1
(en)
*
|
2017-07-20 |
2019-01-24 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
RECOMBINANT ANTIBODIES BINDING TO CD123
|
|
WO2019018169A1
(en)
|
2017-07-21 |
2019-01-24 |
Amgen Inc. |
PERMEABLE GAS SEALING ELEMENT FOR MEDICINE CONTAINER AND METHODS OF ASSEMBLY
|
|
JP7242562B2
(ja)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法
|
|
EP4085942A1
(en)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
CN110892267B
(zh)
|
2017-08-01 |
2024-08-09 |
安进公司 |
用于对样品进行实时聚糖测定的系统和方法
|
|
EP3662287B1
(en)
|
2017-08-01 |
2024-02-28 |
Amgen Inc. |
Systems and methods for real time preparation of a polypeptide sample for anaylsis with mass spectrometry
|
|
US12318593B2
(en)
|
2017-08-09 |
2025-06-03 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
US11813426B2
(en)
|
2017-10-06 |
2023-11-14 |
Amgen Inc. |
Drug delivery device including seal member for needle of syringe
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
|
US12053618B2
(en)
|
2017-11-06 |
2024-08-06 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
MX2020004736A
(es)
|
2017-11-10 |
2020-08-13 |
Amgen Inc |
Embolos para dispositivos de administracion de farmacos.
|
|
JP7370969B2
(ja)
|
2017-11-16 |
2023-10-30 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの扉ラッチ機構
|
|
WO2019099322A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
US12247060B2
(en)
|
2018-01-09 |
2025-03-11 |
Marengo Therapeutics, Inc. |
Calreticulin binding constructs and engineered T cells for the treatment of diseases
|
|
WO2019152599A1
(en)
*
|
2018-01-31 |
2019-08-08 |
The Wistar Institute Of Anatomy And Biology |
Nucleic acid monoclonal antibodies targeting pcsk9 and methods of use
|
|
US11629184B2
(en)
|
2018-02-23 |
2023-04-18 |
Remd Biotherapeutics, Inc. |
Calcitonin gene-related peptide (CGRP) antagonist antibodies
|
|
EP3765856B1
(en)
|
2018-03-13 |
2023-09-27 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
WO2019178280A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
CA3105448A1
(en)
|
2018-07-03 |
2020-01-09 |
Elstar Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020028009A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
CN113166241B
(zh)
|
2018-08-16 |
2025-02-25 |
约翰霍普金斯大学 |
人类znt8抗体
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
CA3110529A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
TW202529830A
(zh)
|
2018-10-05 |
2025-08-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
EP3866889A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
EP3866890A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Drug delivery device having damping mechanism
|
|
ES3010833T3
(en)
|
2018-11-01 |
2025-04-04 |
Amgen Inc |
Drug delivery devices with partial drug delivery member retraction
|
|
EP3873563A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
TWI852964B
(zh)
|
2018-12-14 |
2024-08-21 |
美商安進公司 |
與依照斜率的蛋白質濃度確定一起使用之系統適用性方法
|
|
EP3924083B1
(en)
|
2019-02-14 |
2024-05-15 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
|
CA3127817A1
(en)
|
2019-02-20 |
2020-08-27 |
Amgen Inc. |
Methods of determining protein stability
|
|
CN119039441A
(zh)
|
2019-02-21 |
2024-11-29 |
马伦戈治疗公司 |
与nkp30结合的抗体分子及其用途
|
|
WO2020172571A1
(en)
|
2019-02-21 |
2020-08-27 |
Elstar Therapeutics, Inc. |
Multifunctional molecules that bind to t cell related cancer cells and uses thereof
|
|
CA3130462A1
(en)
|
2019-03-04 |
2020-09-10 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
|
US12078701B2
(en)
|
2019-03-27 |
2024-09-03 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
|
ES3032751T3
(en)
|
2019-04-24 |
2025-07-24 |
Amgen Inc |
Syringe sterilization verification assemblies and methods
|
|
ES2997211T3
(en)
|
2019-06-05 |
2025-02-14 |
Amgen Inc |
Methods of identifying attributes of therapeutic proteins
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
WO2021058597A1
(en)
|
2019-09-24 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of determining whether a subject is at risk of developing arterial plaques
|
|
US12366570B2
(en)
|
2019-10-01 |
2025-07-22 |
The Johns Hopkins University |
Cell-based ZNT8 assay
|
|
JP2023509708A
(ja)
|
2020-01-03 |
2023-03-09 |
マレンゴ・セラピューティクス，インコーポレーテッド |
抗ｔｃｒ抗体分子およびその使用
|
|
BR112022020428A2
(pt)
*
|
2020-04-09 |
2023-03-07 |
Verve Therapeutics Inc |
Edição base do angptl3 e métodos de uso do mesmo para tratamento de doenças
|
|
GB202008860D0
(en)
*
|
2020-06-11 |
2020-07-29 |
Univ Oxford Innovation Ltd |
BTLA antibodies
|
|
KR20210158693A
(ko)
*
|
2020-06-24 |
2021-12-31 |
바이오스트림테크놀러지스(주) |
항 ｐｃｓｋ９ 항체 및 이의 용도
|
|
MX2023003164A
(es)
|
2020-09-18 |
2023-05-04 |
Amgen Inc |
Metodos de procesamiento de una muestra para analisis de mapeo de peptidos.
|
|
CA3200262A1
(en)
|
2020-11-05 |
2022-05-12 |
Amgen Inc. |
Materials and methods for protein processing
|
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
|
EP4387666A4
(en)
*
|
2021-08-20 |
2025-07-16 |
Univ Johns Hopkins |
CELL SURFACE ANTIBODY FOR A PANCREATIC BETA CELL SPECIFIC BIOMARKER
|
|
US20250368753A1
(en)
|
2021-10-21 |
2025-12-04 |
Flagship Pioneering Innovations Vi, Llc |
Modulators of proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
CA3237662A1
(en)
|
2021-11-09 |
2023-05-19 |
Amgen Inc. |
Production of therapeutic proteins
|
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
|
WO2024259275A1
(en)
|
2023-06-14 |
2024-12-19 |
Bristol-Myers Squibb Company |
Near real time sialic acid quantitation of glycoproteins
|
|
WO2025101602A1
(en)
|
2023-11-07 |
2025-05-15 |
Amgen Inc. |
Methods of analyzing amino acid content of a therapeutic protein
|
|
WO2025144700A1
(en)
|
2023-12-27 |
2025-07-03 |
Absci Corporation |
Nanobody library screening using bacterial surface display
|
|
WO2025255028A1
(en)
|
2024-06-03 |
2025-12-11 |
Amgen Inc. |
High-throughput liquid chromatography-mass spectrometry-based peptide mapping
|
|
CN118791609B
(zh)
*
|
2024-09-13 |
2024-11-26 |
江苏凯基生物技术股份有限公司 |
一种抗igf-1的单克隆抗体及制备方法及试剂盒及应用
|